Insect cells as a factory to produce adeno-associated virus type 2 vectors

Human Gene Therapy

Volumn 13, Issue 16, 2002, Pages 1935-1943

  Urabe, Masashi ^a   Ding, Chuantian ^a   Kotin, Robert M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM; CESIUM CHLORIDE; CHLORIDE; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL ADHESION; CELL LINE; DENSITY GRADIENT CENTRIFUGATION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; INSECT; METABOLISM; MOUSE; PLASMID; RETINA; SOUTHERN BLOTTING; WESTERN BLOTTING; ADENOVIRUS; ANIMAL CELL; BACULOVIRUS; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN CELL; INSECT CELL; INVERTEBRATE; NONHUMAN; PARTICULATE MATTER; PHYSICAL PARAMETERS; TIME; VIRUS GENOME;

ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CENTRIFUGATION, DENSITY GRADIENT; CESIUM; CHLORIDES; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INSECTS; LUMINESCENT PROTEINS; MICE; MODELS, GENETIC; PLASMIDS; RETINA; TRANSCRIPTION, GENETIC; TRANSFECTION;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ADENOVIRIDAE; ANIMALIA; AUTOGRAPHA; AUTOGRAPHA CALIFORNICA; AUTOGRAPHA CALIFORNICA NUCLEOPOLYHEDROVIRUS; CYPOVIRUS; INSECTA; INVERTEBRATA; MAMMALIA; UNIDENTIFIED BACULOVIRUS; UNIDENTIFIED NUCLEAR POLYHEDROSIS VIRUSES;

EID: 0036431701     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340260355347     Document Type: Article

References (27)

1. Bergoin, M., and Tijssen, P. (1998). Biological and molecular properties of densoviruses and their use in protein expression and biological control. In The Insect Viruses. L.K. Miller and L.A. Ball, eds. (Plenum, New York) pp. 141-169.
2. Berns, K.I. (1996). Parvoviridae: The viruses and their replication. In Virology. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, and B. Roizman, eds. (Lippincott-Raven, Philadelphia) pp. 2173-2197.
3. Chiorini, J.A., Wendter, C.M., Urclay E., Safer, B., Hallek, M., and Kotin, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541
4. Clark, K.R. (2002). Recent advances in recombinant adeno-associated virus vector production. Kidney Int. 61(Suppl. 1), 9-15.
5. Clark, K.R., Voulgaropoulou, F., Fraley, D.M., and Johnson, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
6. Flannery, J.G., Zolotukhin, S., Vaquero, M.I., Lavail, M.M., Muzyczka, N., and Hauswirth, W.W. (1997). Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 94, 6916-6921.
7. Gao, G.P., Qu, G., Faust, L.Z., Engdahl, R.K., Xiao, W., Hughes, J.V., Zoltick, P.W., and Wilson, J.M. (1998). Hightiter adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9, 2353-2362.
8. Grimm, D., Kern, A., Rittner, K., and Kleinschmidt, J.A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9, 2745-2760.
9. Hermonat, P.L., Labow, M.A., Wright, R., Berns, K.I., and Muzyczka, N. (1984). Genetics of adeno-associated virus: Isolation and preliminary characterization of adeno-associated virus type 2 mutants. J. Virol. 51, 329-339.
10. Inoue, N., and Russell, D.W. (1998). Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J. Virol. 72, 7024-7031.
11. Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L.J., Shimada, T., and Young, N.S. (1991). Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. U.S.A. 88, 4646-4650.
12. Kaplitt, M.G., Leone, P., Samulski, R.J., Xiao, X., Pfaff, D.W., O'Malley, K.L., and During, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8, 148-154.
13. Kay, M.A., Manno, C.S., Ragni, M.V., Larson, P.J., Couto, L.B., McClelland, A., Glader, B., Chew, A.J., Tai, S.J., Herzog, R.W., Arruda, V., Johnson, F., Scallan, C., Skarsgard, E., Flake, A.W., and High, K.A. (2000). Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24, 257-261.
14. Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P.C., Matelis, L.A., Kurtzman, G.J., and Byrne, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93, 14082-14087.
15. King, J.A., Dubielzig, R., Grimm, D., and Kleinschmidt, J.A. (2001). DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J. 20, 3282-3291.
16. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Lowy, D.R., and Schiller, J.T. (1993). Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67, 6929-6936.
17. Koeberl, D.D., Alexander, I.E., Halbert, C.L., Russell, D.W., and Miller, A.D. (1997). Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 94, 1426-1431.
18. Kotin, R.M. (1994). Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5, 793-801.
19. Muzyczka, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.
20. Ruffing, M., Zentgraf, H., and Kleinschmidt, J.A. (1992). Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 66, 6922-6930.
21. Snyder, R.O., Miao, C.H., Patijn, G.A., Spratt, S.K., Danos, O., Nagy, D., Gown, A.M., Winther, B., Meuse, L., Cohen, L.K., Thompson, A.R., and Kay, M.A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270-276.
22. Summerford, C., and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
23. Surosky, R.T., Urabe, M., Godwin, S.G., McQuiston, S.A., Kurtzman, G.J., Ozawa, K., and Natsoulis, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71, 7951-7959.
24. Theilmann, D.A., and Stewart, S. (1991). Identification and characterization of the IE-1 gene of Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus. Virology 180, 492-508.
25. Tratschin, J.D., Miller, I.L., and Carter, B.J. (1984). Genetic analysis of adeno-associated virus: Properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J. Virol. 51, 611-619.
26. Wistuba, A., Kern, A., Weger, S., Grimm, D., and Kleinschmidt, J.A. (1997). Subcellular compartmentalization of adenoassociated virus type 2 assembly. J. Virol. 71, 1341-1352.
27. Xiao, X., Li, J., and Samulski, R.J. (1998). Production of hightiter recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.